36C24418R0112-001.docx

36C24418R0112

PAGE 1 OF

1. REQUISITION NO.

2. CONTRACT NO.

3. AWARD/EFFECTIVE DATE

4. ORDER NO.

5. SOLICITATION NUMBER

6. SOLICITATION ISSUE DATE

a. NAME

b. TELEPHONE NO. (No Collect Calls)

8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY

CODE

10. THIS ACQUISITION IS

UNRESTRICTED OR

SET ASIDE:

% FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ

IFB

RFP

15. DELIVER TO

CODE

16. ADMINISTERED BY

CODE

17a. CONTRACTOR/OFFEROR

CODE

FACILITY CODE

18a. PAYMENT WILL BE MADE BY

CODE

TELEPHONE NO.

DUNS:

DUNS+4:

PHONE:

FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19.

20.

21.

22.

23.

24.

ITEM NO.

SCHEDULE OF SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA

26. TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________

29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED

SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION

(REV. 2/2012)

PREVIOUS EDITION IS NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS

595-18-3-070-0003 36C24418R0112 01-26-2018 Mark Knorr

(570) 824-3521 x 7222 02-28-2018

4:30 PM EST

00244 Department of Veterans Affairs Network Contracting Office 4

X 621512 $15 Million X N/A X 00595 Department of Veterans Affairs Lebanon, PA Medical Center 1700 South Lincoln Ave Lebanon PA 17042 00244 Department of Veterans Affairs Network Contracting Office 4

Austin Payment Center Department of Veterans Affairs PO Box 149971 Austin TX 78714-9971

(877) 353-9791

(512) 460-5429 Onsite Mobile PET/CT Scan Trailer Services in accordance with Performance Work Statement and Price/Cost Schedule starting on page 8.

X X X Shawn Smith Table of Contents

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

(continuation from Standard Form 1449, block 18A.)

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Mark Knorr, Administering Contract Specialist, Mark.Knorr@va.gov Shawn Smith, Contracting Officer, Shawn.Smith@va.gov

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

3. INVOICES: Invoices shall be submitted in arrears:

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

Austin Payment Center Department of Veterans Affairs PO Box 149971 Austin TX 78714-9971

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

B.2 SPECIAL CONTRACT REQUIREMENTS

Under the authority of Public Law 104-262 and 38 USC 8153, the contractor agrees to provide Health Care Resources in accordance with the terms and conditions stated herein, to furnish to and at the Department of Veterans Affairs Medical Center, , the services and prices specified in the Section entitled Schedule of Supplies/Services of this contract.

1. SERVICES:

a. The services specified in the Sections entitled Schedule of Supplies/Services and Special Contract Requirements may be changed by written modification to this contract.

b. Other necessary personnel for the operation of the services contracted for at the VA will be provided by the VA at levels mutually agreed upon which are compatible with the safety of the patient and personnel and with quality medical care programming.

c. The services to be performed by the contractor will be performed in accordance with VA policies and procedures and the regulations of the medical staff by laws of the VA facility.

2. TERM OF CONTRACT:

This contract is effective one year from date of award plus four (4) one-year options that may be exercised by the VA. The contract is subject to the availability of funds. The contractor shall perform no services after September 30 of any year until the Contracting Officer authorizes such services in writing.

3. QUALIFICATIONS:

Personnel assigned by the Contractor to perform the services covered by this contract shall be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia. All licenses held by the personnel working on this contract shall be full and unrestricted licenses. The qualifications of such personnel shall also be subject to review by the VA Chief of Staff and approval by the VA Facility Director. Each person assigned to work under this contract shall be licensed by .

4. WORK HOURS:

a. The services covered by this contract shall be furnished by the contractor as defined herein. The contractor will not be required, except in case of emergency, to furnish such services during off-duty hours as described below.

b. The following terms have the following meanings:

(1) Work hours: Monday through Friday, 8:00 a.m. - 4:30 p.m.

(2) National Holidays: The 10 holidays observed by the Federal Government are:

New Year’s Day Martin Luther King’s Birthday Presidents Day Memorial Day Independence Day Labor Day Columbus Day Veterans Day Thanksgiving Christmas AND any other day specifically declared by the President of the United States to be a national holiday.

(3) Off-Duty hours: Friday through Monday, 4:30 p.m. - 8:00 a.m.

5. PERSONNEL POLICY:

The contractor shall be responsible for protecting the personnel furnishing services under this contract. To carry out this responsibility, the contractor shall provide the following for these personnel:

- general liability

- workers compensation

- professional liability insurance

- health examinations

- income tax withholding, and

- social security payments.

The parties agree that the contractor, its employees, agents and subcontractors shall not be considered VA employees for any purpose.

6. RECORD KEEPING:

The VA Medical Center, Lebanon, PA shall establish and maintain a record keeping system that will record the hours worked by the contractor employee(s). Contractor's employee(s) shall report to Administrative Officer and/or Contracting Officer Representative (COR) at the Lebanon, PA VAMC, or designee upon arrival at the .

7. CONTRACT PERFORMANCE MONITORING:

Monitoring of contractors time shall be demonstrated through sign-in/ sign-out sheets. The contractor shall be required to sign an attendance log upon reporting to work and departing from work. , shall be the VA official responsible for verifying contract compliance. After contract award, any incidents of contractor noncompliance as evidenced by the monitoring procedures shall be forwarded immediately to the Contracting Officer.

8. KEY PERSONNEL AND TEMPORARY EMERGENCY SUBSTITUTIONS:

The Contractor shall assign to this contract the following key personnel:

a. During the first ninety (90) days of performance, the Contractor shall make NO substitutions of key personnel unless the substitution is necessitated by illness, death, or termination of employment. The Contractor shall notify the Contracting Officer, in writing, within 15 calendar days after the occurrence of any of these events and provide the information required by paragraph (c) below. After the initial 90-day period of the contract, the Contractor shall submit the information required by paragraph (c) to the Contracting Officer at least 15 days prior to making any permanent substitutions.

b. The Contractor shall provide a detailed explanation of the circumstances necessitating the proposed substitutions, complete resumes for the proposed substitutes, and any additional information requested by the Contracting Officer. Proposed substitutes shall have comparable qualifications to those of the persons being replaced. The Contracting Officer will notify the Contractor within 15 calendar days after receipt of all required information of the decision on the proposed substitutes. The contract will be modified to reflect any approved changes of key personnel.

c. For temporary substitutions where the key person will not be reporting to work for three (3) consecutive work days or more, the Contractor will provide a qualified replacement for the key person. This substitute shall have comparable qualifications to the key person. Any period exceeding two weeks will require the procedure as stated above.

B.3 LIMITATIONS ON SUBCONTRACTING-- MONITORING AND COMPLIANCE (JUN 2011)

This solicitation includes VAAR 852.219-10 VA Notice of Total Service- Disabled Veteran-Owned Small Business Set-Aside. Accordingly, any contract resulting from this solicitation will include this clause. The contractor is advised in performing contract administration functions, the CO may use the services of a support contractor(s) retained by VA to assist in assessing the contractor's compliance with the limitations on subcontracting or percentage of work performance requirements specified in the clause. To that end, the support contractor(s) may require access to contractor's offices where the contractor's business records or other proprietary data are retained and to review such business records regarding the contractor's compliance with this requirement. All support contractors conducting this review on behalf of VA will be required to sign an “Information Protection and Non-Disclosure and Disclosure of Conflicts of Interest Agreement” to ensure the contractor's business records or other proprietary data reviewed or obtained in the course of assisting the CO in assessing the contractor for compliance are protected to ensure information or data is not improperly disclosed or other impropriety occurs. Furthermore, if VA determines any services the support contractor(s) will perform in assessing compliance are advisory and assistance services as defined in FAR 2.101, Definitions, the support contractor(s) must also enter into an agreement with the contractor to protect proprietary information as required by FAR 9.505-4, obtaining access to proprietary information, paragraph (b). The contractor is required to cooperate fully and make available any records as may be required to enable the CO to assess the contractor's compliance with the limitations on subcontracting or percentage of work performance requirement.

B.4 PRICE/COST SCHEDULE

The Contractor shall furnish all personnel to provide services necessary to perform onsite Mobile PET/CT Scan Trailer Services to eligible beneficiaries of the Department of Veterans Affairs Medical Center, Lebanon, PA VA Medical Center (hereinafter referred to as LVAMC). The contractor’s technologist care shall cover the range of PET/CT Services as would be provided in a state-of-the-art civilian medical treatment facility and the standard of care shall be of a quality, meeting or exceeding currently recognized national standards.

Place of Performance: Services shall be provided on site, VAMC Lebanon, 1700 South Lincoln Avenue, Lebanon, PA 17042

Pricing Instructions:

The offeror is instructed to include all other than price and cost information supporting the proposed price as directed in Instructions to Offerors addendum to 52.212-1 and/or Section D- Contract Documents, Exhibits, or attachments, VA Directive 1663 Appendix B. The Contractor shall propose the adequate number of personnel to be credentialed and be available for scheduling to meet the requirements of the contract.

Note: The Government shall order the below specified minimum contract value of services and may order up to and including the below specified maximum contract value of services through task orders under this basic IDIQ contract throughout the duration of the contract to include all option periods (if applicable). The maximum amount under this contract is not guaranteed.

IDIQ contract Minimum $ 200,000.00

IDIQ contract Maximum $3,000,000.00

Contract Period: 5/18/18 – 5/17/23

ITEM INFORMATION

Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; limited area (e.g., chest, head/neck)

Ordering Period: 05-18-2018 – 05-17-2019

24.00

EA

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; skull base to mid-thigh

Ordering Period: 05-18-2018 – 05-17-2019

275.00

EA

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; whole body

Ordering Period: 05-18-2018 – 05-17-2019

40.00

EA

Procedure Description Myocardial imaging, positron emission tomography (PET), metabolic evaluation

Ordering Period: 05-18-2018 – 05-17-2019

12.00

EA

Procedure Description Myocardial imaging, positron emission tomography (PET), perfusion, single study at rest or stress

Ordering Period: 05-18-2018 – 05-17-2019

1.00

EA

Procedure Description Brain imaging, positron emission tomography (PET); metabolic evaluation

Ordering Period: 05-18-2018 – 05-17-2019

15.00

EA

Procedure Description [F-18]fluoro-2-deoxy-D-glucose (FDG) is an analog of glucose and localizes in high concentration in some normal tissues (heart, brain, and liver) and most malignant tumors. Use of this imaging technique in oncology is based on the observation that malignant tissues have a higher uptake of FDG than do the surrounding normal tissues.

Ordering Period: 05-18-2018 – 05-17-2019

311.00

EA

Procedure Description [F-18] sodium fluoride (NaF) is a positron-emitting boneseeking agent that localizes in high concentration in the skeleton. Its uptake mechanism resembles that of Tc-99m MDP. After intravenous administration, [F-18]fluoride ion diffuses through the capillaries into the bone extracellular fluid.

Ordering Period: 05-18-2018 – 05-17-2019

20.00

EA

Procedure Description [F-18]florbetapir (AV-45, Amyvid®) is a small molecule stilbene derivative that binds selectively to human -amyloid neuritic plaques with nanomolar affinity. The brain uptake of florbetapir reflects the regional density of neuritic plaques measured at autopsy.

Ordering Period: 05-18-2018 – 05-17-2019

6.00

EA

Procedure Description A radioactive diagnostic agent for positron emission tomography (PET) imaging to locate somostatin receptor positive neuroendocrine tumors in adult and pediatric patients. Neuroendocrine tumors have receptors for somatostatin, a hormone that regulates the endocrine system. 68Ga-Dotatate , a positron emitting analogue of somatostatin, works by binding to such receptors. The uptake of 68Ga-Dotatate reflects the level of somatostatin receptor density in neuroendocrine tumors.

6.00

EA

F-18 Fluciclovine (Axumin™) injection is a diagnostic agent indicated for positron emission tomography imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen levels following prior treatment

Ordering Period 5/18/19 – 5/17/20

24.00

EA

Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; limited area (e.g., chest, head/neck)

Ordering Period: 05-18-2019 – 05-17-2020

25.00

EA

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; skull base to mid-thigh

Ordering Period: 05-18-2019- 05-17-2020

301.00

EA

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; whole body

Ordering Period: 05-18-2019 – 05-17-2020

42.00

EA

Procedure Description Myocardial imaging, positron emission tomography (PET), metabolic evaluation

Ordering Period: 05-18-2019 – 05-17-2020

13.00

EA

CPT Code 78491

Procedure Description Myocardial imaging, positron emission tomography (PET), perfusion, single study at rest or stress

Ordering Period: 05-18-2019 – 05-17-2020

1.00

EA

Procedure Description Brain imaging, positron emission tomography (PET); metabolic evaluation

Ordering Period: 05-18-2019 – 05-17-2020

16.00

EA

Procedure Description [F-18]fluoro-2-deoxy-D-glucose (FDG) is an analog of glucose and localizes in high concentration in some normal tissues (heart, brain, and liver) and most malignant tumors. Use of this imaging technique in oncology is based on the observation that malignant tissues have a higher uptake of FDG than do the surrounding normal tissues.

Ordering Period: 05-18-2019 – 05-17-2020

327.00

EA

Procedure Description [F-18] sodium fluoride (NaF) is a positron-emitting boneseeking agent that localizes in high concentration in the skeleton. Its uptake mechanism resembles that of Tc-99m MDP. After intravenous administration, [F-18]fluoride ion diffuses through the capillaries into the bone extracellular fluid.

Ordering Period: 05-18-2019 – 05-17-2020

21.00

EA

Procedure Description [F-18]florbetapir (AV-45, Amyvid®) is a small molecule stilbene derivative that binds selectively to human -amyloid neuritic plaques with nanomolar affinity. The brain uptake of florbetapir reflects the regional density of neuritic plaques measured at autopsy.

Ordering Period: 05-18-2019 – 05-17-2020

7.00

EA

A radioactive diagnostic agent for positron emission tomography (PET) imaging to locate somostatin receptor positive neuroendocrine tumors in adult and pediatric patients. Neuroendocrine tumors have receptors for somatostatin, a hormone that regulates the endocrine system. 68Ga-Dotatate , a positron emitting analogue of somatostatin, works by binding to such receptors. The uptake of 68Ga-Dotatate reflects the level of somatostatin receptor density in neuroendocrine tumors.

Ordering Period: 05-18-2019 –

7.00

EA

F-18 Fluciclovine (Axumin™) injection is a diagnostic agent indicated for positron emission tomography imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen levels following prior treatment

Ordering Period: 05-18-2019-

Ordering Period 5/18/20 – 5/17/21

36.00

EA

Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; limited area (e.g., chest, head/neck)

Ordering Period: 05-18-2020 – 05-17-2021

26.00

EA

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; skull base to mid-thigh

Ordering Period: 05-18-2020 – 05-17-2021

327.00

EA

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; whole body

Ordering Period: 05-18-2020 – 05-17-2021

44.00

EA

Procedure Description Myocardial imaging, positron emission tomography (PET), metabolic evaluation

Ordering Period: 05-18-2020 – 05-17-2021

14.00

EA

Myocardial imaging, positron emission tomography (PET), perfusion, single study at rest or stress

Ordering Period:

05-18-2020 – 05-17-2021

1.00

EA

Procedure Description Brain imaging, positron emission tomography (PET); metabolic evaluation

17.00

EA

Procedure Description [F-18]fluoro-2-deoxy-D-glucose (FDG) is an analog of glucose and localizes in high concentration in some normal tissues (heart, brain, and liver) and most malignant tumors. Use of this imaging technique in oncology is based on the observation that malignant tissues have a higher uptake of FDG than do the surrounding normal tissues.

Ordering Period: 05-18-2020 – 05-17-2021

343.00

EA

Procedure Description [F-18] sodium fluoride (NaF) is a positron-emitting boneseeking agent that localizes in high concentration in the skeleton. Its uptake mechanism resembles that of Tc-99m MDP. After intravenous administration, [F-18]fluoride ion diffuses through the capillaries into the bone extracellular fluid.

Ordering Period: 05-18-2020 – 05-17-2021

22.00

EA

Procedure Description [F-18]florbetapir (AV-45, Amyvid®) is a small molecule stilbene derivative that binds selectively to human -amyloid neuritic plaques with nanomolar affinity. The brain uptake of florbetapir reflects the regional density of neuritic plaques measured at autopsy.

Ordering Period: 05-18-2020 – 05-17-2021

8.00

EA

A radioactive diagnostic agent for positron emission tomography (PET) imaging to locate somostatin receptor positive neuroendocrine tumors in adult and pediatric patients. Neuroendocrine tumors have receptors for somatostatin, a hormone that regulates the endocrine system. 68Ga-Dotatate , a positron emitting analogue of somatostatin, works by binding to such receptors. The uptake of 68Ga-Dotatate reflects the level of somatostatin receptor density in neuroendocrine tumors.

Ordering Period: 05-18-2020-

8.00

EA

F-18 Fluciclovine (Axumin™) injection is a diagnostic agent indicated for positron emission tomography imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen levels following prior treatment

Ordering Period 5/18/21 – 5/17/22

48.00

EA

Procedure Description

Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; limited area (e.g., chest, head/neck)

Ordering Period: 05-18-2021 – 05-17-2022

27.00

EA

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; skull base to mid-thigh

Ordering Period: 05-18-2021- 05-17-2022

348.00

EA

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; whole body

Ordering Period: 05-18-2021 – 05-17-2022

46.00

EA

Procedure Description Myocardial imaging, positron emission tomography (PET), metabolic evaluation

Ordering Period: 05-18-2021 – 05-17-2022

15.00

EA

Procedure Description Myocardial imaging, positron emission tomography (PET), perfusion, single study at rest or stress

Ordering Period: 05-18-2021 – 05-17-2022

1.00

EA

Procedure Description Brain imaging, positron emission tomography (PET); metabolic evaluation

Ordering Period:

05-18-2021 – 05-17-2022

18.00

EA

Procedure Description [F-18]fluoro-2-deoxy-D-glucose (FDG) is an analog of glucose and localizes in high concentration in some normal tissues (heart, brain, and liver) and most malignant tumors. Use of this imaging technique in oncology is based on the observation that malignant tissues have a higher uptake of FDG than do the surrounding normal tissues.

Ordering Period:

05-18-2021 – 05-17-2022

360.00

EA

Procedure Description [F-18] sodium fluoride (NaF) is a positron-emitting boneseeking agent that localizes in high concentration in the skeleton. Its uptake mechanism resembles that of Tc-99m MDP. After intravenous administration, [F-18]fluoride ion diffuses through the capillaries into the bone extracellular fluid.

Ordering Period: 05-18-2021 – 05-17-2022

23.00

EA

Procedure Description [F-18]florbetapir (AV-45, Amyvid®) is a small molecule stilbene derivative that binds selectively to human -amyloid neuritic plaques with nanomolar affinity. The brain uptake of florbetapir reflects the regional density of neuritic plaques measured at autopsy.

Ordering Period: 05-18-2021- 05-17-2022

9.00

EA

A radioactive diagnostic agent for positron emission tomography (PET) imaging to locate somostatin receptor positive neuroendocrine tumors in adult and pediatric patients. Neuroendocrine tumors have receptors for somatostatin, a hormone that regulates the endocrine system. 68Ga-Dotatate , a positron emitting analogue of somatostatin, works by binding to such receptors. The uptake of 68Ga-Dotatate reflects the level of somatostatin receptor density in neuroendocrine tumors.

Ordering Period: 05-18-2021-

9.00

EA

F-18 Fluciclovine (Axumin™) injection is a diagnostic agent indicated for positron emission tomography imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen levels following prior treatment

Ordering Period: 05-18-2021 –

Ordering Period 5/18/22-5/17/23

54.00

EA

Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; limited area (e.g., chest, head/neck)

Ordering Period: 05-18-2022 – 05-17-2023

28.00

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; skull base to mid-thigh

Ordering Period: 05-18-2022 -

370.00

Procedure Description Tumor imaging, positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization; whole body

Ordering Period: 05-18-2022 – 05-17-2023

48.00

EA

Myocardial imaging, positron emission tomography (PET), metabolic evaluation

Ordering Period:

05-18-2022 – 05-17-2023

16.00

EA

Procedure Description Myocardial imaging, positron emission tomography (PET), perfusion, single study at rest or stress

Ordering Period: 05-18-2022 – 05-17-2023

1.00

EA

Procedure Description Brain imaging, positron emission tomography (PET); metabolic evaluation

Ordering Period:

05-18-2022 – 05-17-2023

19.00

EA

Procedure Description [F-18]fluoro-2-deoxy-D-glucose (FDG) is an analog of glucose and localizes in high concentration in some normal tissues (heart, brain, and liver) and most malignant tumors. Use of this imaging technique in oncology is based on the observation that malignant tissues have a higher uptake of FDG than do the surrounding normal tissues.

Ordering Period: 05-18-2022 – 05-17-2023

378.00

EA

Procedure Description [F-18] sodium fluoride (NaF) is a positron-emitting boneseeking agent that localizes in high concentration in the skeleton. Its uptake mechanism resembles that of Tc-99m MDP. After intravenous administration, [F-18]fluoride ion diffuses through the capillaries into the bone extracellular fluid.

Ordering Period: 05-18-2022 – 05-17-2023

24.00

EA

[F-18]florbetapir (AV-45, Amyvid®) is a small molecule stilbene derivative that binds selectively to human -amyloid neuritic plaques with nanomolar affinity. The brain uptake of florbetapir reflects the regional density of neuritic plaques measured at autopsy.

10.00

EA

A radioactive diagnostic agent for positron emission tomography (PET) imaging to locate somostatin receptor positive neuroendocrine tumors in adult and pediatric patients. Neuroendocrine tumors have receptors for somatostatin, a hormone that regulates the endocrine system. 68Ga-Dotatate , a positron emitting analogue of somatostatin, works by binding to such receptors. The uptake of 68Ga-Dotatate reflects the level of somatostatin receptor density in neuroendocrine tumors.

Ordering Period: 05-18-2022-

10.00

EA

F-18 Fluciclovine (Axumin™) injection is a diagnostic agent indicated for positron emission tomography imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen levels following prior treatment

60.00

GRAND TOTAL

B.5 PERFORMANCE WORK STATEMENT

MOBILE PET/CT SCAN SERVICES

1.0 BACKGROUND: The Department of Veteran Affairs (VA), Veterans Administration Medical Center (VAMC), provides a wide range of services to Veterans, Veteran's dependent, Surviving spouse, child or parent of a deceased Veteran, Uniformed service member, Present or former reservist or National Guard members.

2.0 SCOPE: This Performance of Work Statement (PWS) defines the requirements for one (1) Mobile Trailer Unit Positron Emission Tomography (PET) and Computed Tomography (CT) services for the VAMC located at Lebanon, Pennsylvania. Contractor shall provide imaging services at least once a week (may increase with volume) with a projected annual volume of approximately 330 scans.

3.0 SUMMARY OF REQUIREMENTS: The Contractor shall provide all personnel, equipment, supplies, and travel necessary to accomplish tasks. The Contractor shall provide a Mobile Trailer Unit to include the PET/CT scanner, processing computer/workstation, hot lab facility and patient preparation/injection area. The Contractor shall provide all medical supplies, instruments and equipment for patient PET/CT Scan and lab facilities. The Contractor shall provide at least one qualified Nuclear Medicine Technologist and qualified support staff such as technical aid and driver required to accomplish tasks.

4.0 SPECIFIC TASKS:

4.1 The Contractor shall screen each patient prior to performing PET/CT procedure. The screening process must be documented and provided to designated radiology staff during each visit.

4.2 The Contractor shall receive patients, explain procedures, answers questions relating to procedure(s), positions patient for all necessary views and tends to their comfort for the duration of the procedure(s).

4.3 Providing or producing, securing, administering and disposal of all radio-isotopes and by-products needed for the study in conformance with applicable federal, state and VA regulations.

4.4 The Contractor shall scan data and transfer to the VAMC PACS and RIS by intranet link or by disc.

4.5 The Contractor shall receive the radiopharmaceuticals at the Mobile Unit.

4.6 The Contractor shall provide studies for interpretation via intranet.

5.0 CONTRACTOR QUALIFICATIONS

5.1 Nuclear Medicine Technologist experience in performing PET/CT and one (1) support person to operate the unit. The Nuclear Medicine technologist shall be fully trained/qualified and shall be AART (N) or NMTCB certified at the time of contract award.

5.2 Mobile Unit Trailer Driver shall be licensed as applicable to operate and drive the mobile vehicle in which the unit is housed.

5.3 The Contractor shall have a valid and current Nuclear Regulatory Commission (NRC) and Pennsylvania State License for isotopes.

5.4 The Contractor shall maintain HIPAA compliance to maintain security and integrity of patient medical record and sensitive personal information.

5.5 The Contractor employees shall be Cardiopulmonary Resuscitation (CPR) qualified and are authorized to perform this life-saving act if necessary.

5.6 The Contractor and the Contractor Employees providing services under this contract shall be able to provide evidence of current Immunizations/testing, and have received training in infection control procedures.

6.0 EQUIPMENT AND MEDICAL SUPPLY STANDARDS

6.1 The Contractor shall insure that all PET/CT and all other equipment utilized during the performance of this contract meet standard medical requirements and are in good working condition.

6.2 The Contractor shall ensure that all equipment is kept safe and in sanitary conditions. This shall include allowing periodic inspections by facility personnel.

6.3 The Contactor shall ensure that all medical supplies utilized during the performance of this contract meet standard medical requirements.

7.0 CONTRACTOR RESPONSIBLIITIES:

7.1 The Contractor shall provide all labor, supplies, materials, equipment, and mobile trailer necessary to perform the work specified in this PWS.

7.2 The Contractor shall be responsible to ensure that Contractor personnel providing work on this contract are fully trained and completely competent to perform the required work.

7.3 The Contractor shall ensure all certifications are current through the term of the contract and if renewal is required it shall be the contractor’s responsibility to ensure it is accomplished without interruption to services being provided.

7.4 The Contractor shall provide a copy of one (1) certification/license for each personnel working the PET/CT Mobile Unit at the time of award and annually (per option year) to the Contracting Officer or the Contracting Officer Representative (COR). In addition, Mobile Trailer Unit PET/CT insurance/license shall be provided to the Contracting Officer or the COR.

7.5 The Contractor shall provide a list of Key Personnel who will be assigned to this contract. If key personnel are removed or replaced with temporary personnel contractor shall contact the contracting officer and the COR immediately with replacement personnel name and required certificate/documentation.

7.6 The Contractor will maintain a stock of expendable supplies and an approved container for storing supplies. The Contractor shall determine the appropriate stock levels required.

7.7 The Contractor shall adhere to the local VAMC policies and procedures and the medical staff by-laws of the Lebanon, PA VA facility.

7.8 The Contractor shall replace all failed equipment prior to the next scheduled work day/week.

7.9 Neither the Contractor nor the contract personnel shall in any way undertake the practice of medicine, render medical opinions or services other than those services required to support the well-being of the patient, or in any way with the patient other than to provide all ancillary and technical service required for the operation of the unit.

7.10 The Contractor personnel shall comply with the facilities performance evaluation, competency and training requirements.

7.11 The Contractor shall comply with Department of Veterans Affairs, Lebanon, PA VAMC Information Security policies as stated in Security Clause.

8.0 SAFETY PRECAUTIONS AND HYGEINE:

8.1 The Contractor shall use proper hand hygiene and uses personal protective equipment as necessary.

8.2 The Contractor shall maintain a clean and organized work area. Technologist shall ensure that all areas are supplied and equipment is in working order before each use.

8.3 The Contractor shall ensure all Nuclear Medicine, Lebanon, PA VA Medical Center, Veterans Integrated Service Network (VISN), and Radiation Safety Policies are effectively followed.

8.4 The Contractor shall perform required service in accordance with the standards of the Joint Commission; established principles and ethics of the medical profession established by the AMA and ACEP, Nuclear Regulatory Commission (NRC), Department of Transportation (DOT), NHPP, and Occupational Safety and Health Association (OSHA). The Contractor shall adhere to Veterans Health Administration (VHA) regulations and the policies, procedures, and regulations of the Medical Staff by-laws of the Lebanon, PA VAMC.

8.5 The Contractor is responsible for all radiation safety. A copy of the Contractor’s radiation safety program shall be provided to the Contracting Officer and COR before commencing operation with adequate documentation that contract employees have dosimeters and have had DOT and radiation safety training.

9.0 HEALTH REQUIREMENTS

9.1 The Contractor certifies that his/her employees have received the following testing/immunizations within the past year and will maintain coverage during the contract period:

a) Tuberculosis Testing – the PPD test or radiological exam shall be repeated annually.

b) Rubella Testing – all contract personnel shall provide proof of immunization for measles, mumps, rubella, or rubella titer of 1:8 or greater. If the titer is less than 1:0, the rubella immunization must be administered with follow-up documentation provided to the Contracting Officer and the COR.

c) Immunizations – for purposes of infection control, all contract employees shall take required immunizations and any health action required by generally accepted public health standards and any immunizations necessitated by any outbreaks in the area/community. Contract personnel will not be allowed to perform duty until such required immunization documentation is provided. Required immunizations include but not limited to; measles, mumps, varicella, acellular pertussis and influenza.

d. Health Restrictions – contract employees shall have no health or physical disability restrictions which interfere with the performance of duties.

10.0 CONFIDENTIALITY

10.1 All contractor personnel shall observe the requirements imposed on sensitive data and information by law, Federal regulations, VA statutes and policy, Veterans Health Administration (VHA) policy and guidelines and the associated requirements to ensure appropriate screening of all personnel (e.g., Privacy Act of 1974, public Law 93-579, the requirements of the FPM 731, Subchapter 2 under E.O. 10450, etc.).

10.2 In order to maintain patient medical records, the contractor shall have access to the Department of Veterans Affairs System(s) of Records entitle, “Patient Medical Records-VA (24 VA 136).”

10.3 Contractor personnel who obtain access to hardware or media which may store drug or alcohol abuse data, sickle cell anemia treatment records, records of tests or treatment for or infection with Human Immunodeficiency Virus (HIV) or medical quality assurance records protected by 36 U.S.C. 4132 or 3305, as defined by the Department of Veterans Affairs, shall not have access to the records unless absolutely necessary to perform their contractual duties.

10.4 Access to Files: In performance of official duties, the Contractor’s employee(s) who have regular access to printed and electronic files containing sensitive data, which must be protected under the provisions of the Privacy Act of 1974 (5 U.S> C. 552a), and other applicable laws, Federal Regulations, Veterans Affairs statutes and policies. The Contractor’s employee(s) are responsible for (1) protecting that data from unauthorized release or from loss, alteration, or unauthorized deletion and (2) following all applicable regulations and instructions regarding access to computerized files, release of access codes, etc., as set out in a computer access agreement which the Contractor’s employee(s) sign.

11.0 THE JOINT COMMISSION GUIDELINES

11.1 The Contractor must perform the required work in accordance with, The Joint Commission standards. The Contractor is required to develop and maintain the following documents for each Contractor employee working on the contract:

a) Credentials and qualifications for the job

b) A current competency assessment checklist (an assessment of knowledge, skills, abilities and behaviors required to perform a job correctly and skillfully)

c) Proof of knowledge and skills required to provide care for certain patient populations, as appropriate

d) Current performance evaluation supporting ability of Contractor employee to successfully perform the work required in this solicitation

e) Listing of relevant continuing education for the last two years

f) The Contractor will provide current copies of these records upon request, to the VA COR for each Contractor employee working on the contract

12.0 QUALITY CONTROL PROGRAM:

12.1 The Contractor shall develop a quality control plan in accordance with the Contractor’s internal quality procedures. The Contractor shall provide the quality control plan as part of their solicitation. Any revisions made to the Plan shall be approved by the COR and provided no later than (NLT) 10 days after award to the Contracting Officer and COR. Quality Control Plan shall include Contractors approach to manage, oversee, control and document work to ensure compliance with the contract PWS.

12.2 The Government may evaluate the quality of professional and administrative services provided, but retains no control over the medical, professional aspects of services rendered (e.g., professional judgments, diagnosis for specific medical treatment), in accordance with Federal Acquisition Regulation (FAR) 37.401(b).

12.3 The Contractor shall perform quality control inspections of the equipment to ensure equipment is in proper working order.

12.4 The Contractor shall insure guidelines from Nuclear Regulatory Commission (NRC), Department of Transportation (DOT), NHPP, and Occupational Safety and Health Association (OSHA) among others are followed.

12.5 The Contractor shall maintain HIPAA compliance to maintain security and integrity of patient medical record and sensitive personal information.

13.0 WORKING HOURS:

All scheduled contract work shall be accomplished during normal working hours; 7:30AM EST to 4:30PM EST, Monday through Friday unless other mutually satisfactory arrangements have been approved by the Contracting Officer.

14.0 CONTRACTOR CONDUCT: All persons furnished by the Contractor, including subcontractors, are the sole responsibility of the Contractor. The Contractor shall be responsible for their compliance with all laws, rules, and regulations. Contract employees shall not be considered Government employees.

14.1 Identification of Contractor Employees

14.2 The contractor shall provide each employee an identification (ID) badge on contract start date or on employment start date. The ID badge shall be made of nonmetallic material. The badge shall be easily readable and include employee's name, contractor's name, and color photograph.

14.3 Display of ID Badges: Contractor personnel shall wear the ID badge at all times when performing work under this contract to include attending Government meetings. Unless otherwise specified in the contract, each contractor employee shall wear the ID badge in a conspicuous place on the front of exterior clothing and above the waist except when safety or health reasons prohibit such placement.

15.0 GOVERNMENT RESPONSIBILITIES:

15.1 The Government shall provide adequate space for the trailer and cab (space to be determined).

15.2 The Government shall provide telephone and intranet access (for communications and sending images via VAMC Lebanon intranet).

15.3 The Government shall provide a check-in area and restroom facilities for the patients.

15.4 The Government shall provide a COR for this contract.

15.5 The Government shall provide medical staff by-laws of the VA facility and security policies.

15.6 The Government shall be responsible for quality assurance/compliance oversight of the contractor, to include quarterly inspections of the Mobile Trailer Unit.

16. Registration with Contractor Performance Assessment Reporting System As prescribed in Federal Acquisition Regulation (FAR) Part 42.15, the Department of Veterans Affairs (VA) evaluates Contractor past performance on all contracts that exceed $150,000, and shares those evaluations with other Federal Government contract specialists and procurement officials. The FAR requires that the Contractor be provided an opportunity to comment on past performance evaluations prior to each report closing. To fulfill this requirement VA uses an online database, CPARS, which is maintained by the Naval Seal Logistics Center in Portsmouth, New Hampshire. CPARS has connectivity with the Past Performance Information Retrieval System (PPIRS) database, which is available to all Federal agencies. PPIRS is the system used to collect and retrieve performance assessment reports used in source selection determinations and completed CPARS report cards transferred to PPIRS. CPARS also includes access to the federal awardee performance and integrity information system (FAPIIS). FAPIIS is a web-enabled application accessed via CPARS for Contractor responsibility determination information.

Each Contractor whose contract award is estimated to exceed $150,000 requires a CPARS evaluation. A government Focal Point will register your contract within thirty calendar days after contract award and, at that time, you will receive an email message with a User ID (to be used when reviewing evaluations). Additional information regarding the evaluation process can be found at www.cpars.gov or if you have any questions, you may contact the Customer Support Desk as noted on the website.

For contracts with a period of one year or less, the contracting officer will perform a single evaluation when the contract is complete. For contracts exceeding one year, the contracting officer will evaluate the Contractor’s performance annually. Interim reports will be filed each year until the last year of the contract, when the final report will be completed. The report shall be assigned in CPARS to the Contractor’s designated representative for comment. The Contractor representative will have sixty (60) calendar days to submit any comments and re-assign the report to the CO.

Failure for the Contractor’s representative to respond to the evaluation within those sixty (60) calendar days, will result in the Government’s evaluation being placed on file in the database with a statement that the Contractor failed to respond; the Contractor’s representative will be “locked out” of the evaluation and may no longer send comments.

IT CONTRACT SECURITY

VA INFORMATION AND INFORMATION SYSTEM SECURITY/PRIVACY

1. GENERAL

Contractors, contractor personnel, subcontractors, and subcontractor personnel shall be subject to the same Federal laws, regulations, standards, and VA Directives and Handbooks as VA and VA personnel regarding information and information system security.

1. ACCESS TO VA INFORMATION AND VA INFORMATION SYSTEMS

a. A contractor/subcontractor shall request logical (technical) or physical access to VA information and VA information systems for their employees, subcontractors, and affiliates only to the extent necessary to perform the services specified in the contract, agreement, or task order.

b. All contractors, subcontractors, and third-party servicers and associates working with VA information are subject to the same investigative requirements as those of VA appointees or employees who…